#Department of Health and Human Services

A letter from 124 patient groups urges the White House to make drugs more affordable—and spells out how it can do so.

Rachel Levine, MD, currently leads Pennsylvania’s health department and its response to COVID-19.

A coalition of LGBT groups sues the Trump administration over the rule. The lawsuit is “Whitman-Walker Clinic v. HHS.”

That’s the subject of a federal inquiry into the tech giant’s “Project Nightingale” partnership with Ascension.

And yet, you have until December 15 to enroll in Obamacare for coverage beginning January 1.

The change targets LGBT people and those with chronic conditions. Here’s how patient groups and Lambda Legal respond.

In a win for abortion opponents, the Trump administration limits funding of research using fetal tissue.

The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.

The proposal rolls back nondiscrimination policies of the Affordable Care Act, notably for transgender people and women who had abortions.

The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.

Plans will be able to add restrictions on certain drugs to treat diseases like cancer, requiring patients to first try cheaper drugs.

Health coalition warns the federal government: People with chronic or serious conditions face growing costs at the pharmacy.

In the past, he was accused of misusing data, showing religious bias and discriminating against gay men and people with HIV.

He’ll oversee the FDA, Medicare and Medicaid at a time when soaring drug prices remain a contentious political topic.

U.S. lawmakers say appointing Azar is like putting “the pharmaceutical fox in charge of the health care henhouse.”

A controversial congressman, he already wrote a plan to replace Obamacare.